Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 1G
Jourdeuil K et al. (2025)
|
Xla Wt + zmym2
NF16-18 (in situ hybridization)
|
|
|
|
Fig. 1GH
Jourdeuil K et al. (2025)
|
Xla Wt + zmym2
NF32 (in situ hybridization)
|
|
|
|
Fig. 5 A
Griffin C et al. (2025)
|
Xtr Wt + sf3b4 CRISPR
NF40 (in situ hybridization)
|
|
|
|
Fig. 4 B B'
Pera EM et al. (2024)
|
Xla Wt + htra1
NF41 (in situ hybridization)
|
|
|
|
Fig. 4 D D'
Pera EM et al. (2024)
|
Xla Wt + serpine2 MO
NF41 (in situ hybridization)
|
|
|
|
Fig. 2 de
Alasaadi DN et al. (2024)
|
Xla Wt + deflation
NF15 (in situ hybridization)
|
|
|
|
Fig. 2 de
Alasaadi DN et al. (2024)
|
Xla Wt + Inflation
NF15 (in situ hybridization)
|
|
|
|
Fig.1.E
Wang H et al. (2021)
|
Xla Wt + fermt2 MO
NF15 (in situ hybridization)
|
|
|
|
Fig.1.D
Wang H et al. (2021)
|
Xla Wt + fermt2 MO
NF15 (in situ hybridization)
|
|
|
|
Fig.1.E
Wang H et al. (2021)
|
Xla Wt + fermt2 MO
NF15 (in situ hybridization)
|
|
|